Picture Berlin Partner Life Sciences Report 2019/2020 Brandenburg 650x80px
Organisation › Details

Exscientia (Group)

Exscientia is at the forefront of Artificial Intelligence (AI)-driven drug discovery and design. By fusing the power of AI with the discovery experience of seasoned drug hunters, Exscientia is the first company to automate drug design, surpassing conventional approaches. Exscientia’s innovative Centaur Chemist™ platform enables breakthrough productivity gains as well as new approaches to improve drug efficacy. Novel compounds are automatically designed and prioritised for synthesis by its AI systems, which rapidly evolve compounds towards the desired candidate criteria for clinical development. Exscientia systems learn from both existing data resources and experimental data from each design cycle. The principle is similar to how a human would learn, but the AI process is far more effective at identifying and assimilating multiple subtle and complex trends to balance potency, selectivity and pharmacokinetic criteria. As a result, the AI-driven process is more likely to achieve the end goal and to do this more rapidly and efficiently than traditional human endeavour. Exscientia is collaborating with several leading pharmaceutical and life sciences companies, including GSK, Sanofi, Evotec, Roche and Celgene Exscientia has its headquarters in Oxford, UK with offices in the UK, USA and Japan. *


Period Start 2016-04-26 existent
Products Industry drug discovery
  Industry 2 small-molecule cancer drug
Person Person Hopkins, Andrew (Ex Scientia 201604 CEO)
Region Region Oxford, Oxfordshire
  Country United Kingdom (GB)
  Street 36 St. Giles’
  City OX1 3LD Oxford, Oxfordshire
  Tel +44-1865-818941
    Address record changed: 2019-04-22
Basic data Employees n. a.
    * Document for �About Section�: Exscientia Ltd.. (3/22/19). "Press Release: Exscientia Continues Expansion with Establishment of a Subsidiary in Japan to Target the Pharmaceutical Market Across Asia". Oxford & Osaka.
Record changed: 2020-04-04


Picture [iito] Männer Ballett 650x80px

More documents for Exscientia (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Picture EBD Group BioPharm America 2020 Digital Event BEU2020 650x81

» top